TITLE:
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

CONDITION:
Head and Neck Neoplasms

INTERVENTION:
tirapazamine (SR259075)

SUMMARY:

      The trial will compare the efficacy and safety of concomitant chemoradiation with
      tirapazamine, cisplatin and radiation versus cisplatin and radiation.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Previously untreated squamous cell carcinoma of the oral cavity, oropharynx,
             hypopharynx, or larynx.

          -  Stage III or IV disease (excluding T1N1, and T2N1).

          -  ECOG performance status less than or equal to 2.

          -  Absolute neutrophil count at least 1.5 X 10^9/L, platelet count at least 100 X
             10^9/L, and hemoglobin > 9g/dL.

          -  Serum bilirubin < 1.25 times ULN and AST/ALT < 2.5 times ULN.

          -  Calculated creatinine clearance (Cockcroft-Gault) > 55 mL/min.

        Exclusion Criteria:

          -  Metastatic Disease
      
